non-linear regression curve fitting program graphpad prism v. 2.01 (GraphPad Software Inc)
90
Structured Review
GraphPad Software Inc
non-linear regression curve fitting program graphpad prism v. 2.01
Non Linear Regression Curve Fitting Program Graphpad Prism V. 2.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+curve+fitting+program+graphpad+prism+v%2E+2%2E01/prism+curve+fitting+software/pm11163328-77-7-12
Average 90 stars, based on 1 article reviews
Non Linear Regression Curve Fitting Program Graphpad Prism V. 2.01, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/non-linear+regression+curve+fitting+program+graphpad+prism+v%2E+2%2E01/prism+curve+fitting+software/pm11163328-77-7-12
Average 90 stars, based on 1 article reviews
non-linear regression curve fitting program graphpad prism v. 2.01 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor. Article Snippet: The 2-amino-benzoylthiophene derivative PD81,723 [(2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone] has been shown to allosterically enhance agonist binding and function at the adenosine A1 receptor.. The aim of the present study was to elucidate the effects of PD81,723 both as an allosteric enhancer and as an antagonist on the adenosine A1 receptor.. We investigated its effect on the human wild-type in relation to a mutant (T277A) adenosine A1 receptor for which agonists have a greatly diminished affinity. |